Hans Vetter

Q: What Schools Are Affiliated With Hans Vetter

Hans Vetter is affiliated with the following schools: University of Bonn, University of Münster

Hans Vetter's AcademicInfluence.com Rankings

Hans Vetter

Biology

#9335

World Rank

#12529

Historical Rank

Endocrinology

#118

World Rank

#129

Historical Rank

biology Degrees

Download Badge

Biology

Hans Vetter's Degrees

PhD Cellular and Molecular Biology Stanford University

Why Is Hans Vetter Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hans Vetter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cardiac myocytes and fibroblasts contain functional estrogen receptors 1 (1997) (408)
Estrogen modulates AT1 receptor gene expression in vitro and in vivo. (1998) (396)
The body/venous hematocrit ratio: its constancy over a wide hematocrit range. (1953) (381)
Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. (2003) (362)
Reliability of reporting self-measured blood pressure values by hypertensive patients. (1998) (294)
Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. (1997) (288)
A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. (2002) (223)
Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. (2004) (209)
Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. (1998) (199)
17β-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo (1999) (186)
Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). (1999) (175)
Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro. (1998) (171)
Application of the "-Omic-" technologies in phytomedicine. (2007) (162)
HYPERPROLACTINÆMIA AND ANTIHYPERTENSIVE EFFECT OF BROMOCRIPTINE IN ESSENTIAL HYPERTENSION Identification of Abnormal Central Dopamine Control (1977) (156)
Antiinflammatory effects of euclyptol (1.8-cineole) in bronchial asthma: inhibition of arachidonic acid metabolism in human blood monocytes ex vivo. (1998) (151)
Thromboxane A2 and vascular smooth muscle cell proliferation. (1995) (147)
Compliance in hypertension: facts and concepts. (1985) (135)
Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone. (1973) (134)
Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. (2001) (129)
Changes in antihypertensive therapy--the role of adverse effects and compliance. (1998) (129)
Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. (2005) (126)
Effects of estrogen on skeletal myoblast growth. (1997) (125)
Twenty-four-hour blood pressure is not dependent on endogenous circadian rhythm. (1989) (120)
Activation of estrogen receptor β is a prerequisite for estrogen‐dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes (2001) (113)
Drug development from natural products: exploiting synergistic effects. (2010) (107)
Toll‐like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis (2006) (105)
Radioimmunoassay for aldosterone without chromatography. (1973) (99)
The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. (1998) (98)
Arterial blood pressure. Correlation with erythrocyte count, hematocrit, and hemoglobin concentration. (1991) (92)
Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. (1998) (92)
New perspectives for synergy research with the "omic"-technologies. (2009) (90)
Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension. (1982) (86)
Differential effects of 17[3‐estradiol on mitogen‐activated protein kinase pathways in rat cardiomyocytes (1999) (84)
Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes (1993) (82)
Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. (1976) (82)
17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. (1999) (81)
Head and Neck Squamous-Cell Cancer and its Association with Polymorphic Enzymes of Xenobiotic Metabolism and Repair (2008) (81)
Stromal cell‐derived factor 1α (SDF‐1α) induces gene‐expression of early growth response‐1 (Egr‐1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation (2003) (79)
BTNL2 gene variant and sarcoidosis (2006) (78)
Evidence that lipoproteins are carriers of bioactive factors. (1999) (76)
Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction. (2000) (73)
Estrogen Modulates AT 1 Receptor Gene Expression In Vitro and In Vivo Brief Rapid Communication (1998) (70)
Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling. (2009) (70)
Diurnal variations of plasma aldosterone in supine man: relationship to plasma renin activity and plasma cortisol. (1975) (67)
Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. (1997) (64)
Differential gene expression in synovium of rheumatoid arthritis and osteoarthritis. (2000) (62)
17&bgr;-Estradiol regulates nNOS and eNOS activity in the hippocampus (2004) (60)
Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells. (2002) (59)
NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer (2000) (58)
The synergistic effect of PDGF-AA and IGF-1 on VSMC proliferation might be explained by the differential activation of their intracellular signaling pathways. (1996) (55)
High Percentage of False-Positive Results of Cytokeratin 19 RT-PCR in Blood: A Model for the Analysis of Illegitimate Gene Expression (2000) (54)
EXP3174, a metabolite of losartan (MK954, DuP753) is more potent than losartan in blocking the angiotensin ll-induced responses in vascular smooth muscle cells (1993) (51)
Modulation of hypertensive heart disease by estrogen (1996) (50)
EPISODIC SECRETION OF ALDOSTERONE IN PRIMARY ALDOSTERONISM: RELATIONSHIP TO CORTISOL (1974) (49)
Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway (2007) (48)
Intracellular Na+ and Ca2+ Activities in Essential Hypertension (1982) (48)
Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. (2004) (48)
[Extrinsic allergic alveolitis]. (2004) (47)
Characterization of angiotensin receptors on human skin fibroblasts (1997) (47)
Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms. (1996) (47)
Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins (2007) (47)
Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells. (1997) (46)
Tele-monitoring of home blood pressure. (2001) (46)
Intracellular Na+ as a genetic marker of essential hypertension. (1981) (46)
Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells (1993) (46)
Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. (2004) (45)
Renin and aldosterone secretion in pheochromocytoma. Effect of chronic alpha-adrenergic receptor blockade. (1976) (45)
Nocturnal hypertension in renal failure, haemodialysis and after renal transplantation. (1989) (44)
Telemonitoring of blood pressure self measurement in the OLMETEL study (2004) (44)
Destabilization of AT1 Receptor mRNA by Calreticulin (2002) (43)
Normal values of blood pressure self-measurement in view of the 1999 World Health Organization-International Society of Hypertension guidelines. (2000) (43)
Clinical differences between benign and malignant pheochromocytomas. (2001) (42)
Antihypertensive drug treatment and fibrinolytic function. (1998) (41)
A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomaldominant inherited congenital heart disease (2007) (41)
Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts (1999) (39)
Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway (2001) (39)
Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation (2002) (39)
ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring (2003) (39)
Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low-density lipoproteins (2002) (38)
17β‐Estradiol regulates the expression of endothelin receptor type B in the heart (2003) (38)
Hypertension associated with multiple renal arteries may be renin‐dependent (2000) (38)
ALLERGIC SKIN REACTIONS TO TRANSDERMAL CLONIDINE (1983) (37)
Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen. (1997) (37)
Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone. (1978) (37)
Neutrophil-elastase in chronic inflammatory bowel disease: a marker of disease activity? (1999) (37)
Can secondary hypertension be identified by twenty-four-hour ambulatory pressure monitoring? (1989) (37)
Regulation of aldosterone secretion in primary aldosteronism. (1975) (37)
The Ets 1 transcription factor is upregulated during inflammatory angiogenesis in rheumatoid arthritis (2002) (35)
Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells (2008) (35)
The growth-promoting effect of low-density lipoprotein may Be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway. (1997) (35)
Effects of n-3 fatty acids on renal function and renal prostaglandin E metabolism. (1990) (35)
The induction of early response genes in rat smooth muscle cells by PDGF‐AA is not sufficient to stimulate DNA‐synthesis (1993) (34)
SCINTIGRAPHIC LOCALIZATION OF PHAEOCHROMOCYTOMAS (1984) (33)
[131I]-META-IODOBENZYLGUANIDINE IN TREATMENT OF MALIGNANT PHAEOCHROMOCYTOMAS (1983) (33)
Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cells. (1996) (33)
Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. (1993) (32)
Lysophosphatidic acid stimulates protein kinase C isoforms α, β, ε, and ζ in a pertussis toxin sensitive pathway in vascular smooth muscle cells (1999) (32)
Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women (2004) (32)
Twenty-four-hour blood pressure profiles in patients with mild-to-moderate hypertension: moxonidine versus captopril. (1994) (32)
Radioimmunoassay for aldosterone without chromatography. Determination of urinary 18-glucuronide excretion (1973) (31)
Cytokine-inducible growth factor gene expression in human umbilical endothelial cells. (1999) (31)
Multiple benign symmetric lipomatosis--a differential diagnosis of obesity: is there a rationale for fibrate treatment? (2008) (31)
Primary aldosteronism: diagnosis and noninvasive lateralization procedures. (1985) (31)
Reverse transcriptase-polymerase chain reaction (RT-PCR): a sensitive method to examine basic fibroblast growth factor-induced expression of the early growth response gene-1 (egr-1) in human umbilical arterial endothelial cells. (1995) (31)
Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism (1999) (31)
Association between head and neck cancer and microsomal epoxide hydrolase genotypes (2002) (31)
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth (1998) (30)
The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients (2000) (30)
Epidermal growth factor stimulates Rac1 and p21-activated kinase in vascular smooth muscle cells. (2008) (30)
Long-term experience with captopril in severe hypertension. (1982) (30)
Adrenalectomy in primary aldosteronism: a long-term follow-up study. (1985) (29)
Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat. (1993) (29)
Evaluation of the performance of a wrist blood pressure measuring device with a position sensor compared to ambulatory 24-hour blood pressure measurements. (2002) (29)
The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar—Kyoto rats (1992) (28)
Real-time genotyping of cytochrome P4501A1 A4889G and T6235C polymorphisms. (2001) (28)
Influence of oxidized low‐density lipoprotein on vascular angiotensin II receptor expression (1997) (28)
Kinetics of Na+/H+ exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester. (1995) (27)
Effects of moexiprilat on oestrogen‐stimulated cardiac fibroblast growth (1997) (26)
Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers. (2010) (26)
Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck. (2001) (26)
Management of patients with uncontrolled arterial hypertension – the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCT (2006) (25)
Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth. (1995) (25)
Polymorphic metabolic susceptibility genes and longevity: a study in octogonarians. (2004) (25)
Early intracellular signalling pathway of ethanol in vascular smooth muscle cells (1999) (25)
Renal venous renin activity in various forms of curable renal hypertension. (1981) (25)
Intracellular Sodium and Calcium in Vascular Smooth Muscle of Spontaneously Hypertensive Rats (1984) (25)
Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism. (2008) (24)
Tropisetron inhibits serotonin‐induced PGE2 release from macrophage‐like synovial cells in serum‐free tissue culture (2004) (24)
Effects of captopril on fibrinolytic function in healthy humans. (1997) (24)
Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome (2007) (24)
Hyperosmotic stress induces immediate-early gene expression in ventricular adult cardiomyocytes. (1993) (24)
Measurement of 8-arginine-vasopressin by radioimmunoassay. Development and application to urine and plasma samples using one extraction method. (1984) (24)
Fibrinolytic function in diuretic-induced volume depletion. (2000) (23)
Angiotensin II induces formation of the early growth response gene‐1 protein in rat vascular smooth muscle cells (1992) (23)
Native low-density lipoprotein (LDL) induces the expression of the early growth response gene-1 in human umbilical arterial endothelial cells. (1995) (23)
High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. (1993) (23)
Intracellular cation activities and concentrations in spontaneously hypertensive and normotensive rats. (1981) (22)
Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism. (1990) (22)
Zinc metabolism during captopril treatment. (1985) (22)
[Non-small-cell lung carcinoma]. (2004) (22)
Pulse wave velocity is increased in patients with transient myocardial ischemia (2004) (21)
The lymphocyte Na+/H+ antiport: activation in primary hypertension and during chronic NaCl‐loading (1994) (21)
Angiotensin type-1 (AT1) receptor gene expression in primarily cultured human arterial umbilical endothelial cells. (1997) (21)
Taste sensitivity for sodium chloride in hypotensive, normotensive and hypertensive subjects. (1987) (20)
Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus. (1981) (20)
Relationship between the Frequency of Blood Pressure Self-Measurement and Blood Pressure Reduction with Antihypertensive Therapy (2006) (20)
Role of mitogen-activated protein kinase in the angiotensin II-induced DNA synthesis in vascular smooth muscle cells. (1998) (20)
Renal excretion of magnesium and trace elements during cisplatin treatment. (1982) (20)
Cell-cycle arrest in G0/G1 phase of growth factor-induced endothelial cell proliferation by various calcium channel blockers. (1997) (20)
CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells. (1996) (19)
Detection of alpha-1-antitrypsin PiZ individuals by SSCP and DNA sequencing in formalin-fixed and paraffin-embedded tissue: a comparison with immunohistochemical analysis. (2000) (19)
Myocardial ischemia during everyday life in patients with arterial hypertension: prevalence, risk factors, triggering mechanism and circadian variability (2006) (19)
Primary aldosteronism: treatment with trilostane. (1985) (19)
Multiple Benign Symmetric Lipomatosis—A Differential Diagnosis of Obesity. Is There a Rationale for Fibrate Treatment? (2008) (19)
Regulation of angiotensin AT1 receptor gene expression during cell growth of vascular smooth muscle cells. (1996) (19)
Rapid analysis of α1-antitrypsin PiZ genotype by a real-time PCR approach (2000) (19)
Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease. (1996) (19)
The Renin-Angiotensin-Aldosterone System in Patients with Nephrotic Syndrome: (1980) (19)
Significance of blood pressure self-measurement as compared with office blood pressure measurement and ambulatory 24-hour blood pressure measurement in pharmacological studies. (2003) (18)
Competitive reverse transcription/polymerase chain reaction for the quantification of p53 and mdm2 mRNA expression. (1996) (18)
Intracellular Na+ and Ca2+ in aortic smooth muscle cells after enzymatic isolation in spontaneously hypertensive rats (1983) (17)
Diurnal variations of blood pressure in shift workers during day and night shifts (1989) (17)
Multiple Benign Symmetric Lipomatosis—A DifferentialDiagnosis of Obesity (2008) (17)
Plasma lipids and lipoproteins and essential hypertension (1994) (17)
Compliance with salt restriction as a limiting factor in the primary prevention of hypertension. (1985) (17)
High titre antiserum specific to aldosterone. (1974) (16)
The spectrum of renovascular hypertension. (1985) (16)
[Muscle weakness]. (1993) (16)
Effects on blood pressure of cross circulation between spontaneously hypertensive and normotensive rats. (1986) (16)
The fibrinolytic system in chronic renal failure. (2001) (16)
SHORT‐TERM FLUCTUATIONS IN PLASMA CORTISOL IN CUSHING'S SYNDROME (1977) (16)
Short‐Term Effects of Exogenous Angiotensin II on Plasma Fibrinolytic Balance in Normal Subjects (2004) (16)
Pavlovian conditioning of corticotropin-releasing factor-induced increase of blood pressure and corticosterone secretion in the rat. (1992) (16)
Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth. (2001) (15)
Long‐term effects of a complex behavioral treatment of essential hypertension. (1987) (15)
Lysophosphatidic acid stimulates protein kinase C isoforms alpha, beta, epsilon, and zeta in a pertussis toxin sensitive pathway in vascular smooth muscle cells. (1999) (15)
Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease. (1995) (15)
Treatment of resistant hypertension by phlebotomy (1985) (14)
Intracellular chloride in essential hypertension. (1985) (14)
Effects of authentic and VLDL hydrolysis‐derived fatty acids on vascular smooth muscle cell growth (2001) (14)
Association of CYP 1 B 1 Codon 432 Mutant Allele in Head and Neck Squamous Cell Cancer Is Reflected by Somatic Mutations of p 53 in Tumor Tissue (2001) (14)
Mitogenic signals control translation of the early growth response gene-1 in myogenic cells. (1994) (14)
Tumour necrosis factor-α gene expression and production in human umbilical arterial endothelial cells (2000) (13)
Identification of p54(nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells. (2005) (13)
Cholesterol enhances platelet-derived growth factor-BB-induced [Ca2+]i and DNA synthesis in rat aortic smooth muscle cells. (1997) (13)
Fish oil and baroreceptor function in man. (1990) (13)
Reliability of non-invasively acquired human genomic DNA as a substrate for real-time PCR-assisted analysis of genetic polymorphisms (2004) (13)
Intracellular sodium and calcium during antihypertensive treatment. (1985) (13)
Potassium load in spontaneously hypertensive rats. Effects on blood pressure, renin-angiotensin, aldosterone, and intracellular electrolytes (1983) (13)
Circadian rhythm of plasma renin activity and plasma aldosterone in normal man and in renal allograft recipients. (1975) (13)
Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells. (1995) (12)
The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells. (1996) (12)
Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells. (1992) (12)
Pathogenetic aspects of hypertension in Cushing's syndrome. (1985) (12)
Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism. (1977) (11)
[Raised renin stimulation following orthostasis in unstable or marginal hypertension]. (1972) (11)
[Renovascular hypertension. Prognostic value of renal venous renin determinations (author's transl)]. (1979) (11)
Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 (4N1-1) is inhibited by epigallocatechin gallate but not by prostaglandin E1 (2004) (11)
Effect of nifedipine on blood pressure and on intracellular calcium in arterial hypertension. (1982) (11)
Statistical Methods for Detecting Genetic Interactions: A Head and Neck Squamous-Cell Cancer Study (2008) (11)
Effect of the Na+/H+ antiport inhibitor Hoe 694 on the angiotensin II‐induced vascular smooth muscle cell growth (1996) (11)
Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis. (2006) (11)
Substance P in Rheumatic Diseases (2007) (11)
Platelet cAMP and cGMP in essential hypertension. (1992) (11)
[Arterial stiffness in arterial hypertension. A new risk factor for left ventricular hypertrophy and cardiac insufficiency?]. (2004) (11)
Morning blood pressure surge and the risk of stroke. (2003) (11)
Intracellular sodium and calcium in essential hypertension (1982) (10)
Humoral factors in the pathogenesis of primary hypertension. (1985) (10)
Action of metoprolol, enalapril, diltiazem, verapamil, and nifedipine on cell growth of vascular smooth muscle cells. (1992) (10)
New Evidence of H1-Receptor Independent COX-2 Inhibition by Fexofenadine HCl in vitro (2006) (10)
Enalapril as a first-step agent in essential hypertension: a comparative study with atenolol. (1986) (10)
Problem cases in renovascular hypertension. (1983) (10)
The scored tablet--a source of error in drug dosing? (1985) (10)
[Factors determining compliance in hypertensive patients]. (1982) (10)
Essential hypertension: relationship between renin and blood pressure. (1980) (10)
Circadian rhythm of the renin-angiotensin-aldosterone system. (1974) (9)
Iron-deficiency anemia as the sole manifestation of celiac disease (1994) (9)
Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane. (1995) (9)
Captopril and kidney function in renovascular and essential hypertension. (1986) (9)
Effect of vitamin E and vitamin C on the DNA synthesis of human umbilical arterial endothelial cells (2001) (9)
[Therapy resistant hypertension--significance of electronic compliance monitoring]. (2002) (9)
60 Primary Aldosteronism - Treatment with Trilostane, an Inhibitor of Steroid Biosynthesis (1984) (9)
Membrane transport, sodium balance, and blood pressure regulation. (1991) (9)
[The modified Bonn Malmö protocol (MBMP) in the treatment of acquired haemophilia A]. (2006) (9)
The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians (2001) (9)
Identification of a phosphodiesterase I/nucleotide pyrophosphatase-related gene mRNA in rat vascular smooth muscle cells by the differential display approach. (1998) (9)
Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle α‐actin content and abolishes the platelet‐derived growth factor‐BB‐stimulated DNA synthesis (2000) (9)
Intracellular electrolytes during antihypertensive treatment with a loop diuretic. (1984) (9)
Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR. (2000) (9)
Simultaneous recording of blood pressure and ST-segment with combined, triggered ambulatory 24-h devices. (2003) (9)
Humoral factors in primary hypertension. (1985) (9)
Measurement of synergistic effects of a phytopharmaceutical by microarray-analysis (2007) (8)
Macrophage-like synoviocytes display phenotypic polymorphisms in a serum-free tissue-culture medium (2004) (8)
Acute saline infusion induces extracellular acidification and activation of the Na+/H+ exchanger in man (1997) (8)
DRUG COMPLIANCE DECREASES BETWEEN CLINIC VISITS – THE EFFECT OF “WHITE-COAT” COMPLIANCE ON 24-H AMBULATORY BLOOD PRESSURE MONITORING: P1.114 (2000) (8)
Localization procedures in pheochromocytoma and neuroblastoma. (1985) (8)
Comparison of in vitro-activity of commonly used topical glucocorticoids on cytokine- and phospholipase inhibition. (2004) (8)
Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells. (1997) (8)
Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects (2004) (8)
Atenolol versus pindolol: Side-effects in hypertension (2004) (8)
Lipid‐induced changes in vascular smooth muscle cell membrane fluidity are associated with DNA synthesis (1999) (7)
Assessment of intracellular sodium and calcium in essential hypertension during diuretic treatment. (1988) (7)
Transdermal β-Blocker Therapy in Essential Hypertension (1988) (7)
Intracellular electrolytes and hypertension. (1982) (7)
[Patient compliance (author's transl)]. (1982) (7)
Reproterol – A Monomolecular Combination of Orciprenaline and Theophylline: Novel Aspects of Its Mode of Action in Asthma (1999) (7)
Angiotensin converting enzyme inhibitors in the clinic: quality of life. (1987) (7)
Treatment of Factor VIII Inhibitors with Selective IgG Immunoadsorption – a Single Center Experience in 50 Patients with Acquired Hemophilia* (2006) (7)
Decreased gastric prostaglandin E2 synthesis in patients with gastric ulcers and in smokers. (1995) (7)
[Extrarenal fibromuscular hyperplasia with renovascular hypertension (author's transl)]. (1980) (7)
Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro. (2004) (7)
Angiotensin II-induced Stimulation of p 21-activated Kinase and c-Jun NH 2-terminal Kinase Is Mediated by Rac 1 and Nck * (2001) (7)
Role of kidney and adrenals in the humoral pathogenesis of primary hypertension. (1984) (7)
Clonidine through the skin in the treatment of essential hypertension: is it practical? (1983) (7)
Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers (1992) (7)
Pseudohypertension in hypertensive patients on multiple drug therapy. (1990) (7)
Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia (2004) (7)
A circulating hypertensive factor in spontaneously hypertensive rats and its effects on intracellular free calcium. (1985) (6)
Plasma zinc and magnesium alterations in acute myocardial infarction (1980) (6)
Rapid analysis of alpha1-antitrypsin PiZ genotype by a real-time PCR approach. (2000) (6)
ACE inhibitor versus beta-blocker in the treatment of essential hypertension. (1987) (6)
Ca2+i:K+i ratio and total intracellular calcium in essential and renal hypertension. (1986) (6)
Insulin enhances angiotensin II induced DNA synthesis in vascular smooth muscle cells of the rat (1993) (6)
[Intracellular sodium and calcium as a genetic marker in essential hypertension]. (1981) (6)
Carbocyclic thromboxane A2 enhances the angiotensin II-induced DNA synthesis in smooth muscle cells. (1996) (6)
131I-Metaiodobenzylguanidine – A New Agent for Scintigraphic Imaging and Treatment of Pheochromocytoma (1984) (6)
The use of suppression subtractive hybridization for the study of SDF-1alpha induced gene-expression in human endothelial cells. (2003) (6)
Blood Pressure-Independent Atherogenic and Thromboembolic Mechanisms of the Renin-Angiotensin-Aldosterone System (2001) (6)
Calcium and primary hypertension. (1987) (6)
Intracellular Na+ and Ca2+ activities in aortic smooth muscle cells from spontaneously hypertensive rats (1982) (6)
Ambulatory 24-H Blood Pressure Monitoring in Essential Hypertensives Treated with the Angiotensin-Converting Enzyme Inhibitor Ramipril (1991) (6)
Effects of a high-cholesterol diet on arterial wall thickness and vascular reactivity in young rabbits (1992) (5)
p53 Downregulation in myelodysplastic syndrome – a quantitative analysis by competitive RT-PCR (2001) (5)
[Clinical aspects and diagnosis of jejunal diverticulosis]. (1995) (5)
A circulating hypertensive factor in primary hypertension: effect of antihypertensive therapy. (1987) (5)
Tumour necrosis factor-alpha gene expression and production in human umbilical arterial endothelial cells. (2000) (5)
Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach (2006) (5)
[Primary aldosteronism: diagnosis, laterality and regulation of hormone secretion]. (1975) (5)
Prescription patterns and costs of antihypertensive drugs in two outpatient clinics: Zürich (Switzerland) and Münster (FRG), 1975-1985. (1987) (5)
Risk of Hepatitis C After Immunoadsorption (2002) (5)
Intracellular Calcium in Hypertension: Effect of Treatment with β‐Adrenoreceptor Blockers (1986) (5)
Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy (1993) (5)
Primary aldosteronism due to adrenal carcinomas (1984) (5)
Toll-like receptor (TLR) 4 Asp299Gly and Thr399Ile polymorphisms are associated with a chronic progressive course of pulmonary sarcoidosis (2006) (5)
Long-term effect of captopril on kidney function in various forms of hypertension (1984) (5)
The effect of saralasin (1-Sar-8-Ala-Angiotensin II) on blood pressure in patients with cushing's syndrome (1976) (5)
Transdermal clonidine application: Long-term results in essential hypertension (1984) (5)
[Experiences with the use of an intravascular 6 French endosonography catheter in vivo]. (1990) (5)
A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer. (2005) (5)
Efficacy of low dose captopril once daily in diuretic resistant hypertension. (1986) (5)
The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study. (1988) (5)
Lateralization procedures in primary aldosteronism (1980) (5)
Identification of Nck Interacting Proteins in Vascular Smooth Muscle Cells (2004) (5)
Baroreceptor activity in man during administration of the calcium channel blocker felodipine. (1990) (5)
Sodium and calcium in lymphocytes and erythrocytes in essential hypertension. (1983) (5)
Oligodeoxynucleotides directed to early growth response gene-1 mRNA inhibit DNA synthesis in the smooth muscle cell. (1996) (5)
Differential Effects of Fexofenadine on Arachidonic Acid Metabolism in Cultured Human Monocytes (2005) (5)
[Nuclear medical therapy of pheochromocytoma]. (1984) (5)
Short-term high dietary cholesterol in early life induces persistent increases in arterial wall thickness and vascular reactivity to noradrenaline. (1991) (5)
Evidence for cardiovascular remodeling in a patient with Bartter's syndrome (1994) (4)
[Computer-assisted assessment of the 24-hour blood pressure profile in essential and secondary hypertensive patients]. (1987) (4)
A phase II trial of topotecan and radiation therapy for CNS-metastases of patients with solid tumors (2001) (4)
Transdermal Clonidine in Essential Hypertension: Problems During Long-Term Treatment (1985) (4)
Ca2+ metabolism in arteries of spontaneously hypertensive rats: assessment by proton-induced X-ray emission. (1986) (4)
[The effect of vitamin C (ascorbic acid) on glucose tolerance, insulin activity and insulin elimination from the blood]. (1980) (4)
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma (2002) (4)
Comparison of gene- and protein expression profiles of a standarized willow bark extract with Quercetin and non-steroidal antiinflammatory drugs in human chondrocytes (2008) (4)
[Ambulatory 24-hour blood pressure monitoring before and after dilatation of renal artery stenoses]. (1986) (4)
Inhibition of cyclooxygenase attenuates baroreceptor function and increases the pressor response to norepinephrine in man (2004) (4)
[Renovascular hypertension: comparison between transluminal dilatation and surgical procedures]. (1982) (4)
Magaldrate stimulates endogenous prostaglandin E2 synthesis in human gastric mucosa in vitro and in vivo. (1998) (4)
[Renin-angiotensin-aldosterone system and fibrinolysis]. (2000) (4)
Primary aldosteronism by carcinoma of the adrenal cortex (1987) (4)
Minoxidil and captopril in severe hypertension (1986) (4)
Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I–II study (2005) (4)
Acute effects of torasemide on the renin activity and on intracellular electrolytes in hypertensive patients (1990) (4)
Intracellular free Ca++ and Na+ in primary hypertension in arterial smooth muscle and in red blood cells. (1986) (4)
Comparison of casual ambulatory and self-measured blood pressure in a long-term study with cilazapril and atenolol. (1993) (4)
Production of antisera specific to aldosterone: effect of hapten density and of carrier proteins. (1974) (4)
[Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)]. (1977) (4)
Cholesterol enhances contractile responses in isolated small mesenteric arteries of normotensive and spontaneously hypertensive rats. (1999) (4)
[Nifedipine in hypertensive emergencies and severe hypertension]. (1984) (4)
[Receptor dysfunction as a pathogenetic principle in hormone resistance and metabolic diseases]. (1981) (4)
[Disturbed sodium and calcium exchange in erythrocytes of spontaneously hypertensive rats (author's transl)]. (1981) (4)
A BTNL2 gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease (2007) (4)
Effect of Anaesthesia and Surgery on the Renin Angiotensin-Aldosterone System (1980) (4)
Long-term ECG in pheochromocytoma. (1985) (4)
[Verapamil 240 mg--effective blood pressure reduction by a single dose?]. (1985) (4)
[Endocrine hypertension in primary aldosteronism and in Cushing's syndrome]. (1976) (4)
[An uncommon cause of severe soft tissue bleeding during phenprocoumon treatment]. (2001) (3)
Evidence for a hypertensive factor in the blood of essential hypertensives. (1985) (3)
[Therapy of primary aldosteronism with trilostane]. (1983) (3)
Diagnosis and treatment of phaeochromocytoma with 131I-metaiodobenzylguanidine. (1984) (3)
[Aldosterone in the blood of the adrenal vein in primary aldosteronism]. (1979) (3)
[Silent myocardial ischemia in hypertensive patients]. (2000) (3)
Modified Bonn-Malmö Protocol (2001) (3)
Gangliosides GM1 and GM2 Stimulate Vascular Smooth Muscle Cell Growth and the Mitogen-Activated Protein Kinase Signaling Transduction Pathway (2000) (3)
[Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure]. (1976) (3)
[Special diagnosis in Cushing's syndrome]. (1981) (3)
Treatment of Adults with Clinically Suspected Severe Thrombotic Thrombocytopenic Purpura – Experiences of a Single Centre (2007) (3)
P-608: Can drug-compliance and blood pressure control be improved by self-measurement and electronic reminders? (2001) (3)
[Cyclosporin A in dermatomyositis]. (1984) (3)
[Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome]. (1976) (3)
[The virtual hypertension clinic--telemedicine in the management of arterial hypertension]. (2001) (3)
The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II. (1980) (3)
[Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension]. (2007) (3)
Action of an ACE-inhibitor on myocardial early growth response (1992) (3)
[Circadian rhythm of silent myocardial ischemia. Why morning is so risky for hypertensive patients]. (2003) (3)
Intracellular calcium in essential hypertension. A parameter for assessing effective antihypertensive treatment. (1984) (3)
Hypertonic saline infusion induces activation of the lymphocyte Na+/H+ antiport and cytosolic alkalinization in healthy human subjects (1994) (3)
[Computerized tomography in adrenal diseases with excessive production of hormones]. (1981) (3)
[Clinical picture, diagnosis and therapy of renovascular hypertension]. (1979) (3)
Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in healthy subjects (2000) (3)
Essential hypertension versus secondary hypertension: discrimination by intracellular electrolytes. (1985) (3)
Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension. (1989) (3)
Differential effect of acute angiotensin II type 1 receptor blockade on the vascular and adrenal response to exogenous angiotensin II in humans. (2003) (3)
Myocardial Drainage via Thebesian Veins: Demonstration by Contrast Enhanced Color Doppler (1991) (2)
Elemental and trace element distribution in medical samples: analysis by proton-induced X-ray emission. (1986) (2)
Gliflumide, a new oral antidiabetic of high potency and efficacy. (1975) (2)
[Dyspnea at rest]. (1989) (2)
[Treatment of pheochromocytoma: changes in diagnosis and therapy]. (1988) (2)
[Diagnosis and therapy of hormonally active cancer of the adrenal cortex. Study of 5 cases]. (1981) (2)
54 Interrelations of the Renin-angiotensin System and 8-Arginine-vasopressin: Effect of Captopril During Postural Change (1984) (2)
Weight reduction and salt restriction in hypertension: Effects on blood pressure and intracellular electrolytes (1986) (2)
[Recurrent thrombophlebitis, weakness]. (1989) (2)
P-205: Compliance with antihypertensive therapy. Comparison of losartan, amlodipine and metoprolol in an open prospective trial (2001) (2)
[Computer tomographic localisation in primary aldosteronism. Comparison with adrenal scintigraphy (author's transl)]. (1980) (2)
6th International Consensus Conference on the Treatment of Primary Breast Cancer (1998) (2)
[Typical spontaneous changes in heart rate in pheochromocytoma]. (1985) (2)
Control of plasma aldosterone in a patient with Conn's Syndrome before and during spironolactone medication (1975) (2)
Rare forms of renal hypertension (1981) (2)
[Aldosterone, cortisol and plasma renin activity in pheochromocytoma (author's transl)]. (1974) (2)
Dietary fat, hypertension, atherosclerosis. (1990) (2)
[Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance]. (1983) (2)
Blood pressure and intracellular electrolytes during weight reduction. (1985) (2)
Captopril before and after spironolactone therapy in primary aldosteronism (1985) (2)
P-25: Clinical evaluation of a wrist blood pressure device with an active positioning system by comparison with 24-H ambulatory blood pressure measurement (2001) (2)
The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome. (1976) (2)
Contrast enhanced color Doppler — basics and potential clinical value (1993) (2)
[Specific scintigraphy in pheochromocytoma]. (1982) (2)
[Diagnostic aspects of 24-hour blood pressure determination]. (1987) (2)
[Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives]. (1980) (2)
Treatment of Pheochromocytomas with 131I-Metaiodobenzylguanidine (1986) (2)
[Acute purulent parotitis as a sequela of alkylphosphate (E 605) poisoning]. (1990) (2)
Short-term stimulation of vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces. (2000) (2)
[Recurrent spontaneous hemorrhage in a patient with light chain immunocytoma]. (2002) (2)
[24-hour blood pressure and ECG monitoring in patients with arterial hypertonia -- importance of silent myocardial ischemia]. (2004) (2)
A stop codon polymorphism of toll-like receptor 5 is associated with a stable course of chronic obstructive lung disease (2006) (2)
Assessment of magnesium and aluminum in erythrocytes by the laser microprobe mass analyzer (LAMMA). (1984) (2)
[Regulation of aldosterone secretion in anephric patients]. (1981) (2)
Identification of p 54 nrb and the 14-3-3 Protein HS 1 as TNF-α-Inducible Genes Related to Cell Cycle Control and Apoptosis in Human Arterial Endothelial Cells (2005) (2)
Diuretic drugs in hypertension and their effect on the renin-angiotensin-aldosterone system (1976) (2)
Evidence for Structural Alterations in Resistance Arteries of Patients with Severe Congestive Heart Failure (1999) (2)
[Recurrent respiratory tract infections]. (1995) (2)
Long-term insulin treatment of vascular smooth muscle cells from rat aorta attenuates the synergistic effect of insulin on angiotensin II- and epidermal growth factor-induced DNA synthesis. (1993) (2)
[Diagnosis and differential diagnosis of swollen leg]. (1989) (2)
Aldosteronsekretion beim primären Aldosteronismus (1975) (1)
[Hypertension in unilateral (non-vascular) nephrosclerosis: renin activity in the venous kidney blood and effect of nephrectomy]. (1979) (1)
[Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension]. (1996) (1)
Immunohistological evaluation of thirty-six pheochromocytomas with regard to proteohormone secretion and proliferation. (1987) (1)
Scintigraphy in pheochromocytoma (1982) (1)
[Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension]. (1976) (1)
Captopril in Cushing's syndrome (1984) (1)
[Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance]. (1982) (1)
Estrogens and the prevention of cardiac apoptosis (2000) (1)
Activation of Na+/H+ exchanger is not involved in the PDGF-BB-induced DNA-synthesis in vascular smooth muscle cells. (1996) (1)
Percutaneous transluminal angioplasty of renal artery stenoses (1987) (1)
[Upper abdominal pain]. (1988) (1)
[Clinico-psychologic therapy of essential hypertension]. (1984) (1)
Preparation of an antiserum specific to aldosterone and its application in radioimmunoassay (1974) (1)
[Restrictive cardiomyopathy caused by cardiac amyloidosis in multiple myeloma]. (1992) (1)
[Rare variants and unusual course of Cushing's syndrome]. (1989) (1)
[Eyelid and ankle edema]. (1990) (1)
[Treatment of hypertension today]. (1988) (1)
33. Antisera specific to corticosterone (1974) (1)
TRANSLATIONAL BLOCK OF THE EGR-1 MESSENGER-RNA IN DIFFERENTIATION OF SOL8 MYOBLASTS (1994) (1)
Age- and sex-related differences in plasma aldosterone in essential hypertension. Relationship to plasma renin activity (1979) (1)
Ca2+ analysis in arteries of spontaneously hypertensive rats by proton-induced X-ray emission. (1985) (1)
Night-day variations of renin-activity in primary aldosteronism. (1979) (1)
[Swelling of the ears, chest pain, cough]. (1996) (1)
Intracellular calcium during beta-adrenoreceptor blockade in essential hypertension. (1986) (1)
INDUCTION OF A MYOCARDIAL IMMEDIATE-EARLY GENE PROGRAM BY THE MECHANICAL, BUT NOT THE ELECTRICAL COMPONENT OF CONTRACTION (1993) (1)
PREDICTORS OF SILENT MYOCARDIAL ISCHEMIA DETECTED IN DAILY LIFE: P1.269 (2004) (1)
[Mechanism and significance of arteriolar media hypertrophy/ hyperplasia in arterial hypertension. Role of the Na+/H+ antiport]. (1988) (1)
PREOPERATIVE DISTINCTION BETWEEN ADENOMA AND HYPERPLASIA IN PRIMARY ALDOSTERONISM (1975) (1)
Transdermal beta-blocker therapy in essential hypertension. (1988) (1)
Obesity, hypertension and intracellular electrolytes (1983) (1)
[Severe soft tissue infection with bulla formation, sepsis, multiple organ failure]. (1997) (1)
Oxymetazoline enhances epidermal- and platelet-derived growth factor-induced DNA synthesis. (1994) (1)
[Postoperative course in primary aldosteronism]. (1982) (1)
[Cough, dyspnea, hemoptysis]. (1990) (1)
Lipoprotein‐induced expression of the sis oncogene in human arterial endothelial cells (1993) (1)
Production, characterization and clinical application of antisera to cortisol. (1983) (1)
Molecular cloning and sequence analysis of variant TNF-alpha transcripts do not indicate a significant role of gene polymorphism in collagen-induced arthritis. (2003) (1)
[Drug therapy of arterial hypertension. From graduated therapy to the individualized treatment concept]. (2009) (1)
[Cushing syndrome with occult ectopic ACTH production]. (1999) (1)
[Therapy of endocrine-active adrenal cortex carcinoma]. (2008) (1)
[Your patient self-monitors his blood pressure. Other limit values are applicable]. (2000) (1)
[Transdermal clonidine: a new therapeutic approach in essential hypertension?]. (1985) (1)
[Isolated mesenteric fibromatosis]. (1994) (1)
Sarkoidose (Morbus Boeck) (2004) (1)
A Comparative Study Between 100mg Atenolol and 20mg Pindolol Slow-Release in Essential Hypertension (1983) (1)
Intracellular calcium in secondary hypertension. (1987) (1)
The effects of hydrochlorothiazide and losartan on fibrinolytic function in normal subjects (1999) (1)
Long-term opiate receptor antagonism in a patient with panhypopituitarism: effects on appetite, prolactin and demand for vasopressin. (1991) (1)
Zinc concentrations in plasma and erythrocytes in digitalized patients (1981) (1)
[Studies on the differential determination of renin activity in renal venous blood in renal artery stenosis]. (1977) (1)
[Effects of angiotensin II on inflammation mediators in healthy subjects]. (2003) (1)
The evaluation of tissue Ca2+ by proton-induced x-ray emission in the arteries of spontaneously hypertensive and normotensive rats. (1985) (1)
ects of moexiprilat on oestrogen-stimulated cardiac ® broblast growth (1997) (1)
The maximal stimulatory effect of low-density lipoprotein on the cytosolic free calcium ion depends on the presence of its lipid and protein component. (1991) (1)
[Clinical importance of the Na+/H(+) antiporter]. (1992) (1)
Short-term vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces stimulation of [3H]thymidine incorporation without mitosis (2000) (1)
[Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives]. (2003) (1)
The Effect of ??-Adrenoreceptor Blockers on the Intracellular Calcium in Essential Hypertension (1985) (1)
Humoral vasopressor agents in primary hypertension. (1987) (1)
[Rational diagnosis of endocrine forms of hypertension]. (1987) (1)
Intracellular electrolytes and lipid metabolism in obesity. (1983) (1)
Endocrine Aspects of Hypertension (1982) (1)
[Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)]. (1975) (1)
Michael Bursztyn Morning Blood Pressure Surge and the Risk of Stroke (2003) (0)
[Exertional dyspnea, palpitations, atypical chest pains]. (1988) (0)
H22: Effect of acupuncture on peri- and postmenopausal women with mild arterial hypertension (1997) (0)
[Diagnostic value of 24 h blood pressure determination]. (1987) (0)
[Fever of unknown origin]. (1995) (0)
[Risk factor hypertension. The need for effective anti-hypertensive therapy]. (1976) (0)
[Acute toxoplasmosis. Leading symptoms: mostly asymptomatic, cervical lymphadenopathy]. (2004) (0)
[Epigastric pain, retrosternal pressure sensation, heartburn]. (1988) (0)
Clinical Experience with the Modified Bonn-Malmö Protocol since 1996 (2002) (0)
[Intracellular sodium+ and magnesium2+ concentrations in diets containing fats of various degrees of saturation]. (1982) (0)
[Non-invasive methods of localization in pheochromocytoma]. (1983) (0)
[Cushing's syndrome (author's transl)]. (2008) (0)
77 Genetic control of muscle growth by the growth-suppressor gene, p53 (1993) (0)
[Divisible tablets--source of error in therapeutic drug dosages]. (1985) (0)
[Upper abdominal pain, hepatomegaly, fever]. (1985) (0)
Application of proton-induced-X-ray emission (PIXE) to the determination of trace elements in biological samples (1986) (0)
[Calcium antagonists in the treatment of high blood pressure]. (2008) (0)
[24-hour blood pressure determination: therapeutic and prognostic implications]. (1987) (0)
Influence of peridural anesthesia and surgery on the renin angiotensin aldo sterone system (1980) (0)
[Reoperation following aortocoronary bypass. Indications and results]. (1984) (0)
[Effect of a chronic alpha adrenergic receptor blockade on basal secretion of renin in essential hypertension]. (1978) (0)
Zinc and magnesium concentrations in plasma and red blood cells in patients on digitalis medication (1981) (0)
[Abdominal pain, weight loss, tarry stools]. (1994) (0)
[Diuretic-resistant hypertension. Effect of an additional daily single dose of a ACE inhibitor]. (1985) (0)
G-CSF Induced Expansion and Mobilization of Hematopoietic Stem Cells Is Altered by the Matrix Protein Osteopontin. (2006) (0)
[Adrenal cortex carcinoma: diagnosis, therapy and course in 10 cases]. (1992) (0)
[Episodical renin secretion during propranolol and pindolol administration in normal subjects]. (1975) (0)
Thromboxane and prostacyclin during weight reduction in relation to hormonal and electrolyte changes (1984) (0)
[Isolated splenomegaly]. (1996) (0)
Effects of lipoproteins on the expression of the early growth response gene‐1 and on DMA synthesis in rat vascular smooth muscle cells (1993) (0)
Intracellular electrolytes and hormonal parameters during weight reduction. (1984) (0)
[Elevated plasma prolactin concentration in essential hypertension]. (1977) (0)
[Adrenal gland scintigraphy]. (1986) (0)
[Bone pain, polydipsia, polyuria]. (1994) (0)
Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension. (1976) (0)
CYCLICAL MECHANICAL-ACTIVITY AND HYPEROSMOTIC STRESS INDUCE AN IMMEDIATE-EARLY GENE PROGRAM IN MYOCARDIUM (1993) (0)
[Dyspnea, tachycardia]. (1987) (0)
Effect of the angiotensin II receptor antagonist MK 954 on the angiotensin II-induced increase in free cytosolic Ca2+ and growth in vascular smooth muscle cells. (1991) (0)
[Back pain]. (1993) (0)
Rosiglitazone induces apoptosis and suppresses LDL-induced proliferation in vascular smooth muscle cells (2001) (0)
[Effect of oral sodium load on the renin and aldosterone secretion in essential hypertension. Comparison to normal persons]. (1978) (0)
[Antihypertensive therapy in chronic kidney failure. Comparison of pharmacologic effect of metolazone and furosemide]. (1983) (0)
ROLE OF TLR4 IN THE PATHOGENESIS OF LPS‐INDUCED ACUTE LUNG INJURY: 81 (2004) (0)
EVIDENCE FOR A CENTRAL ROLE OF THE EARLY GROWTH-RESPONSE GENE-1 (EGR-1) IN MYOGENIC PROLIFERATION AND DIFFERENTIATION (1994) (0)
Acute suppurative parotitis caused by poisoning with organophosphates (E605). (1990) (0)
Crosstalk between the Estrogen Receptor and the Insulin-Like Growth Factor (IGF-1) Receptor. Implications for Cardiac Disease (1999) (0)
[Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension]. (1976) (0)
[Fifty-three year old patient with tetany]. (2001) (0)
[Transdermal administration of insulin in type II diabetics. Results of a clinical pilot study]. (1990) (0)
[Fever, productive cough, night sweats]. (1989) (0)
Renin, aldosterone and arterial pressure responses to acute β-adrenergic receptor blockade in hypertensive patients (1976) (0)
Diagnostic and therapeutic aspects of 24-h blood pressure measurement (1990) (0)
Joint Meeting of the Benelux Society for Microcirculation (1998) (0)
[Sodium restriction in young people. Report of an interventive study]. (1982) (0)
147 Reduced expression of the sarcolemmal calcium pump ??? a novel abnormality in hypertensive cardiac hypertrophy (1993) (0)
[The renin-angiotension-aldosterone system and cortisol excretion before, during and after enflurane anaesthesia for orthopaedic surgery (author's transl)]. (1980) (0)
[Hemoptysis in silicotic cicatricial emphysema]. (1984) (0)
[Immediate effect of beta receptor blockaders on electrolyte metabolism]. (1982) (0)
Validity of computerized tomography in adrenal diseases. (1981) (0)
Localization of te Adrenal Lesions in Primary Aldosteronism (1983) (0)
[Fever, productive cough, chest pain]. (1990) (0)
Paclitaxel, Carboplatin, and G-CSF in Advanced Non-Small-Cell Lung Cancer: A Phase I/II Study (1998) (0)
[The prevalence of hypertension in patients with roentgenologic signs of pyelonephritis in intravenous pyelography]. (1981) (0)
Psychological Control of High Blood Pressure - Prognostic Criteria and Long-term Effects (1985) (0)
P-255: Short-term effects of exogenous angiotensin II on fibrinolytic function in normal subjects (2002) (0)
[Right abdominal flank pain]. (1989) (0)
308. Episodic secretion of aldosterone in normal man and in various diseases (1974) (0)
128 Effect of the early growth response gene-1 in transduction of endo-/paracrine signals in hypertension (1993) (0)
[Blood pressure and the prevalence of hypertension in polycythemia vera and secondary polyglobulia]. (1983) (0)
Effect of chronic beta-adrenergic blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension (1976) (0)
Cortisol levels in saliva: effects of corticotropin releasing factor and different stressors in normal men (1988) (0)
[Active ion transport in athyroid patients]. (1984) (0)
[Endocrine hypertension: primary aldosteronism and pheochromocytoma]. (1988) (0)
[Thromboangiitis obliterans (M. Winiwarter-Buerger). Main symptoms: acral cyanosis and aches]. (2004) (0)
[Bronchiolitis obliterans with organizing pneumonia (BOOP). Influenza simulating illness with opacity spots in the roentgen image (with no response to antibiotics]. (2004) (0)
Surgical Therapy of Primary Aldosteronism (1983) (0)
[Stress-dependent arm weakness and dizziness]. (1988) (0)
59 Long-term Heart Rate Profiles in Phaeochromocytoma (1984) (0)
[Progressive loss of vision in suspected tumor]. (1995) (0)
[Hemangiosarcoma of the heart]. (1986) (0)
[Transdermal beta blockers: effect on 24-hour blood pressure profile in hypertensive patients]. (1987) (0)
Effects of l-tryptophan and carbohydrates on blood pressure patterns in essential hypertension (1988) (0)
[Primary aldosteronism]. (1976) (0)
[Chronic progressive polycythemia and thrombocytosis]. (2001) (0)
Normal concentrations of serum hyaluronic acid in patients with primary fibromyalgia syndrome. (2004) (0)
Induction of myocardial hypertrophy by growth factors — Role of the early growth response gene-1 (Egr-1) (1992) (0)
LONG-TERM EXPERIENCEWITHCAPTOPRILINSEVERE HYPERTENSION (1982) (0)
[Fatigue, exertional dyspnea, unsteady gait]. (1989) (0)
[Hemorrhagic diathesis]. (1985) (0)
Comparative Studies in Hypertension: Satellite Symposium to the 11th Scientific Meeting of the ISH, Titisee-Neustadt, September 1986: Proceedings (1987) (0)
[Cough, vomiting, rapid weight loss]. (1994) (0)
Circadian pharmacokinetics and converting enzyme inhibition of enalapril maleate in healthy volunteers (1990) (0)
[Rational therapy of hypertension 1985]. (1985) (0)
22 Mechanisms of the Blood Pressure Lowering Effect of K+ in Spontaneously Hypertensive Rats (1984) (0)
[Lipids, intracellular electrolytes and hormonal parameters during weight reduction]. (1983) (0)
Estrogen modulates apoptotic pathways in neonatal and adult cardiac myocytes in vitro and in vivo (1999) (0)
STIMULATION OF MYOBLAST PROLIFERATION BY BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH FACTOR-BB MAY BE MEDIATED BY THE EARLY GROWTH-RESPONSE GENE-1 (EGR-1) (1993) (0)
39 Therapy Resistant Hypertension: Captopril or Minoxidil? (1984) (0)
[Exertional dyspnea, fatigue, palpitations]. (1989) (0)
[Adynamia, finger paresthesias]. (1989) (0)
[Septic fever, joint pains and hepatosplenomegaly]. (1987) (0)
THE FINGERPLETHYSMOGRAPHIC METHOD TO ASSESS PULSEWAVE VELOCITY IS CORRELATED TO AORTIC PULSEWAVE VELOCITY, AUGMENTATION INDEX, AND TO PERIPHERAL ARTERIAL OCCLUSIVE DISEASE: P3.134 (2004) (0)
[Cough, fever and jaundice]. (1987) (0)
[Behavior of arterial vascular contractility in the course of structural vascular changes during a cholesterol diet]. (1991) (0)
G12 - Influence of autohemotherapy with ozone on blood pressure and cardiovascular risk factors in patients with mild hypertension (1995) (0)
[Muscle weakness, polyneuropathy]. (1987) (0)
[Sarcoidosis (Boeck's disease). Inflammatory granulomatous systemic disease which involves especially the lung and lymph nodes]. (2004) (0)
P-442: Angiotensin II does not affect fibrinolytic function in healthy subjects (2001) (0)
[Action of intrinsic low density lipoprotein in the vascular wall. Significance for the pathogenesis of essential hypertension and arteriosclerosis]. (1994) (0)
[Diagnostic value of atrial natriuretic peptide in hypertension and heart insufficiency]. (1987) (0)
C2 Glucose increases proliferation of vascular smooth muscle cells induced by LDL (1997) (0)
49 Weight Reduction and Salt Intake in the Obese (1984) (0)
[Intermittent claudication]. (1984) (0)
Is ambulatory pulse pressure elevated in hypertensive patients with transient myocardial ischemia by 24-h cardiotens monitoring? (2004) (0)
[Radiological diagnosis of adrenal gland diseases]. (1986) (0)
[Internal medicine case report. Hypoglycemia]. (1984) (0)
[Orthostatic hypotension]. (1995) (0)
[Aldosterone and renin in liver cirrhosis with ascites]. (1977) (0)
Simple Photometric Test for Pupillary Dysfunction (1995) (0)
[Hypertension. Individualized treatment as a new therapy concept]. (1991) (0)
[Diagnostic localization and postoperative results of hormone-producing tumors of the adrenal cortex--review of 51 cases]. (1988) (0)
57. High sodium intake activates the lymphocyte sodium-hydrogen antiport system in normotensive subjects (1991) (0)
[Present-day poisonings and their treatment]. (1961) (0)
[Intracellular signal transduction of angiotensin II and possible interventions in the renin-angiotensin system]. (2002) (0)
Subject Index, Vol. 47, 1987 (1987) (0)
Induction of the early growth response gene-1, c-fos, and protein synthesis in adult cardiomyocytes by angiotensin II and endothelin (1991) (0)
[Studies on the action of the antihypertensive agent guancydine. II. Potentiation of the effect by pretreatment with furosemide or mefruside in the rat]. (1971) (0)
[Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system]. (1977) (0)
Subject Index, Vol. 47, 1987 (1987) (0)
[Chronic hemorrhagic pleural effusion in mediastinal pancreatic pseudocyst]. (1991) (0)
SUPPRESSION OF EPISODIC RENIN SECRETION IN NORMAL SUBSECTS BY PROPRANOLOL AND PINDOLOL (1975) (0)
Secondary Hypertension: New Aspects in Diagnosis and Treatment of Renal and Adrenal Hypertension Symposium, Mnster, September 1984 (1985) (0)
[Myeloblastoma, an unusual mediastinal tumor]. (1984) (0)
C003 Lysophosphatidic acid activates protein kinase C isoforms $alpha;, $beta;, $epsi; and $Sigma; in vascular smooth muscle cells (1998) (0)
[Turbo-spin-echo (TSE) sequences with selective fat suppression (SPIR) compared with chemical shift sequences in MRI for differentiation of adrenal tumors. Spectral Presaturation by Inversion Recovery]. (1995) (0)
[Adrenal forms of Cushing syndrome. Problems in preoperative differential diagnosis and application of therapeutic methods]. (1987) (0)
OR-32: Acute angiotensin II type 1 (AT1)-receptor blockade exerts differential effects on the vascular and adrenal response to exogenous angiotensin II in man (2002) (0)
[Weakness, bone pain]. (1990) (0)
Reference values for office Blood pressure measurement cannot be applied to self blood pressure measurement (2000) (0)
C10: The effects of growth factors on DNA synthesis in vascular smooth muscle cells are increased by glucose (1997) (0)
[34-year-old patient with headache attacks and hypokalemic hypertension]. (1998) (0)
[Dyspnea, fever]. (1989) (0)
C9: Effects of low density lipoprotein on thrombin-induced mitogenesis in vascular smooth muscle cells (1997) (0)
Analysis of Ca2+ in aortic tissue: age‐dependent Ca2+ content in spontaneously hypertensive rats and in normotensive controls (1988) (0)
[Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension]. (1976) (0)
Effects of Sphingosylphosphorylcholine on Vascular Smooth Muscle Cell Growth and on the Delayed Growth Response Cell Cycle Proteins Cdk2 and Cdc2 (2000) (0)
[Effect of chronic beta-receptor blockade in blood pressure and renin and aldosterone secretion in essential hypertension]. (1975) (0)
Primary Aldosteronism by Carcinoma of the Adrenal (1987) (0)
[Electrolyte balance in arterial hypertension]. (1980) (0)
P.012 COMPARISON OF OSCILLOMETRIC AND TONOMETRIC DERIVED PULSE WAVE VELOCITY (2006) (0)
Renin- and Aldosterone-Regulation in Hepatic Coma Treated by Baboon Liver Perfusion and in Prolonged Shock (1980) (0)
Exogen allergische Alveolitis (2004) (0)
mRNA-induction of c-Fos and the early growth response gene-1 in vascular smooth muscle cells by the platelet-derived growth factor isoforms (1993) (0)
[Endocrine-active adreno cortical carcinoma: clinical forms and differential diagnosis]. (2008) (0)
[Chronic active sarcoidosis with pleural effusion]. (2004) (0)
Cellular calcium metabolism in primary hypertension (1987) (0)
Calcium modulates the synthesis of prostaglandin E2 in isolated colonic mucosal cells. (1997) (0)
[Calcium antagonists in hypertension therapy]. (1985) (0)
Endocrine and cardiovascular effects of dietary treatments enhancing brain serotoninergic neurotransmission (1988) (0)
Association of sympathetic activity (resting heart rate) with serum cholesterol but not with blood pressure in young normotensive subjects (1999) (0)
[Plasma aldosterone in a patient with primary aldosteronism during and after adenoma excision]. (1973) (0)
P-191 Topotecan and radiation — A new therapeutic concept for CNS-metastases in patients with lung cancer (2003) (0)
Effect of propranolol and prindolol on renin secretion in normal supine man (1975) (0)
$alpha;Thrombin activates protein kinase C isoform $epsiv; in a pertussistoxin-sensitive pathway in vascular smooth muscle cells. (1999) (0)
[Otorhino-laryngological experience in modern poliomyelitis therapy]. (1957) (0)
[Painless increase of abdominal girth]. (1990) (0)
Segmentally associated possible clinical precursors of cytopenic or cell-rich hematologic diseases (1989) (0)
[Weight loss, fever, dyspnea]. (1990) (0)
[Small cell bronchial carcinoma. Main symptoms: cough, hemoptysis, hoarseness, dyspnea, paraneoplastic syndrome., weight loss, neurologic manifestations and post-stenotic pneumonia]. (2005) (0)
Effects of prostaglandin E and A on intracellular electrolytes in human red blood cells (1984) (0)
[Exertional dyspnea, chest pain, dizziness]. (1989) (0)
[Bone pain, spontaneous fractures, muscle weakness]. (1987) (0)
Role of Humoral Factors in the Humoral Pathogenesis of Primary Hypertension (1985) (0)
[Prevalence of diagnoses in ambulatory and hospitalized patients]. (2000) (0)
[Fever and shivering fits]. (1986) (0)
[Acute retrosternal pain]. (1989) (0)
Lack of oral kallikrein in lowering systemic blood pressure in primary hypertension. (1992) (0)
I006: Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in normal subjects (2000) (0)
C8 Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells (1997) (0)
THU0028 Different variants of tnf-alpha mrna transcripts are expressed in rats with collagen-induced arthritis (2001) (0)
[Recurrent diarrhea, epigastric pain radiating to the back]. (1988) (0)
[Advantages of 24-hour ambulatory blood pressure monitoring for the assessment of dose-effect relations and dose-equivalency]. (1992) (0)
[Aldosterone secretion in primary aldosteronism]. (1975) (0)
Parallel Genotyping of Different Genes: A Rapid Real-Time PCR Approach (2002) (0)
Intracellular Electrolytes in Essential Hypertension during Treatment with Torasemide (1987) (0)
Antihypertensiva bei therapieresistenter Hypertonie (1983) (0)
The benefit of ayurvedic diagnostics in treatment strategies for rheumatoid arthritis (2009) (0)
[Polyuria, polydipsia]. (1994) (0)
[Renin-angiotensin-aldosterone system in pheochromocytoma]. (1974) (0)
58 Effects of Diuretics on Intracellular Na+ and Ca2+ in Essential Hypertensives (1984) (0)
[Diuretics and antihypertensive agents in chronic kidney insufficiency: comparison of the effects of metolazone and furosemide]. (1985) (0)
[Forms of adrenal hypertension]. (1988) (0)
[Red-colored lesion of the iris, polylymphadenopathy]. (1987) (0)
Evidence for cardiovascular remodeling in a with Bartter's syndrome (1994) (0)
[Continuous 24-hour blood pressure determination]. (1987) (0)
106 Potential effect of the heart rate in the development of hypertensive cardiac hypertrophy (1993) (0)
[Endocrine hypertension]. (2020) (0)
Trilostane - a new and effective drug for primary aldosteronism. (1985) (0)
P-170: Normal values for exercise blood pressure in the elderly in view of the 1999 WHO blood pressure classification (2002) (0)
[Intracellular electrolytes and serum lipids in relation to dietary fatty acid intake]. (1982) (0)
[Nifedipine in the hypertensive crisis--effect of intravenous administration]. (1985) (0)
DETECTION OF SILENT MYOCARDIAL ISCHEMIA IN HYPERTENSIVE PATIENTS BY SIMULTANEOUS 24-H ELECTROCARDIOGRAPHIC AND BLOOD PRESSURE MONITORING: P1.113 (2000) (0)
[Hypertensive female patients often undertreated or treated too late. Therapy of hypertension needs women's initiative]. (2003) (0)
[Thoracic pain, dyspnea]. (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hans Vetter?

Hans Vetter is affiliated with the following schools: